1. Homepagina
  2. Aandelen
  3. BelgiŽ
  4. Euronext Bruxelles
  5. Mithra Pharmaceuticals S.A.
  6. Nieuws
  7. Persberichten
    MITRA   BE0974283153

MITHRA PHARMACEUTICALS S.A.

(MITRA)
  Rapport
Real Time Euronext Bruxelles  -  17:35 01-07-2022
6.950 EUR   -4.40%
21/06Degroof Petercam verlaagt koersdoel Mithra
AM
21/06Berenberg verlaagt koersdoel voor Mithra met 10 euro
AM
21/06Mithra haalt 23,5 miljoen euro op met private plaatsing
AM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Communiquťs de presse de la sociťtť MITHRA PHARMACEUTICALS S.A.
2021MITHRA PHARMACEUTICALS S A : Releases 2020 Annual Report and Invitation to its Securities ..
PU
2021MITHRA PHARMACEUTICALS S A : Transparency Notification from Alychlo NV
PU
2021MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Alyc..
PU
2021MAYNE PHARMA : And mithra announce fda approval of new oral contraceptive nextstellis
AQ
2021Mayne Pharma and Mithra Announce FDA Approval of New Oral Contraceptive Estelle
AQ
2021Richter and Mithra Receive Positive CHMP Opinion for Estelle
AQ
2021MITHRA PHARMACEUTICALS S A : Richter and Mithra Receive Positive CHMP Opinion for Estelleģ
PU
2021MITHRA PHARMACEUTICALS S A : Reports Full Year 2020 Financial Results
AQ
2021MITHRA PHARMACEUTICALS S A : and Searchlight Pharma Announce Nextstellisģ Approval in Cana..
AQ
2021MITHRA PHARMACEUTICALS S A : to Host Webcast for 2020 Financial Results on 9 March 2021
AQ
2021MITHRA PHARMACEUTICALS S A : and Farmitalia Announce Commercial Launch of Myring in Italy,..
AQ
2021MITHRA PHARMACEUTICALS S A : - Estelle Study Results Published in Leading Peer-Reviewed Me..
AQ
2021MITHRA PHARMACEUTICALS S A : Estelleģ Study Results Published in Leading Peer-Reviewed Med..
PU
2021MITHRA PHARMACEUTICALS S A : - The Board of Directors appoints Leon Van Rompay as CEO ad i..
AQ
2021MITHRA PHARMACEUTICALS S A : - Nomination of Christophe Marechal as interim CEO
AQ
2021MITHRA PHARMACEUTICALS S A : Nomination of Christophe Maréchal as interim CEO
PU
2021MITHRA PHARMACEUTICALS S A : Announces 2021 Financial Calendar
PU
2020MITHRA PHARMACEUTICALS S A : Richter and Mithra strengthen their partnership and signed a ..
AQ
2020MITHRA PHARMACEUTICALS S A : Estetrol recognized as a “New Active Substance” b..
PU
2020MITHRA PHARMACEUTICALS S A : Scientific community convinced of Estetrol's potential for wo..
PU
2020MITHRA PHARMACEUTICALS S A : launches an offering of up to EUR 150 million convertible bon..
PU
2020MITHRA PHARMACEUTICALS S A : exclusivity on Estetrol applications extended to 2036 in Eur
PU
2020MITHRA PHARMACEUTICALS S A : Announces Positive DSMB Safety Review and Continuation of its..
PU
2020MITHRA PHARMACEUTICALS S A : announces placement of EUR 125 million convertible bonds due ..
PU
2020MITHRA PHARMACEUTICALS S A : announces final terms of its offering of EUR 125 million conv..
PU
2020MITHRA PHARMACEUTICALS S A : Richter and Mithra strengthen their partnership and signed a ..
PU
2020MITHRA PHARMACEUTICALS S A : Announces Positive DSMB Safety Review and Continuation of its..
AQ
2020MITHRA PHARMACEUTICALS S A : Announces Positive DSMB Safety Review and Continuation of its..
PU
2020MITHRA PHARMACEUTICALS S A : announces final terms of its offering of EUR 125 million conv..
AQ
2020MITHRA PHARMACEUTICALS S A : announces placement of EUR 125 million convertible bonds due ..
PU
2020MITHRA PHARMACEUTICALS S A : launches an offering of up to EUR 150 million convertible bon..
PU
2020Mithra - Scientific community convinced of Estetrol's potential for women's health
AQ
2020MITHRA PHARMACEUTICALS S A : Scientific community convinced of Estetrol's potential for wo..
PU
2020MITHRA PHARMACEUTICALS S A : exclusivity on Estetrol applications extended to 2036 in Euro..
AQ
2020MITHRA PHARMACEUTICALS S A : exclusivity on Estetrol applications extended to 2036 in Euro..
PU
2020MITHRA PHARMACEUTICALS S A : Estetrol recognized as a 'New Active Substance' by the Europe..
AQ
2020MITHRA PHARMACEUTICALS S A : SA - Creation of a New Share Option Plan in Replacement of th..
AQ
2020MITHRA PHARMACEUTICALS S A : - E4/DRSP, a Novel Combined Oral Contraceptive, submitted to ..
AQ
2020MITHRA PHARMACEUTICALS S A : Signs License and Supply Agreement for Commercialization of M..
AQ
2020MITHRA PHARMACEUTICALS S A : Signs License and Supply Agreement for Commercialization of M..
PU
2020MITHRA PHARMACEUTICALS S A : Renews its Board of Directors to Support its Operational Ambi..
AQ
2020MITHRA PHARMACEUTICALS S A : Signs LSA for Commercialization of Estelle in North Africa
AQ
2020Mithra Announces FDA update
AQ
2020MITHRA PHARMACEUTICALS S A : Announces FDA update
PU
2020MITHRA PHARMACEUTICALS S A : Announces 2020 Half Year Results
AQ
2020MITHRA PHARMACEUTICALS S A : Half Year 2020 Results
PU
2020MITHRA PHARMACEUTICALS S A : Announces 2020 Half Year Results
PU
2020MITHRA PHARMACEUTICALS S A : to Host Webcast for Half Year Financial Results on 24 Septemb..
PU
2020MITHRA PHARMACEUTICALS S A : EGM Approves Warrant Plan for Share Lending Shareholders
AQ
2020MITHRA PHARMACEUTICALS S A : - Publication of a Transparency Notification Received from Al..
AQ
2020MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Alyc..
PU
2020MITHRA PHARMACEUTICALS S A : Announces Commercial Launch of Myring in the Netherlands
AQ
2020MITHRA PHARMACEUTICALS S A : - Notice of Extraordinary Shareholders Meeting on 7th Septemb..
AQ
2020MITHRA PHARMACEUTICALS S A : Notice of Extraordinary Shareholders' Meeting on 7th Septembe..
PU
2020MITHRA PHARMACEUTICALS S A : Information relative au nombre total de droits de vote (dénom..
PU
2020MITHRA PHARMACEUTICALS S A : Announces Shelf Life Extension for Myring™ to 36 Months
PU
2020MITHRA PHARMACEUTICALS S A : Announces Commercial Launch of Tibelia in Canada
AQ
2020MITHRA PHARMACEUTICALS S A : Announces Commercial Launch of Tibeliaģ in Canada
PU
2020MITHRA PHARMACEUTICALS S A : EGM Approves Warrant Plan for LDA Capital
AQ
2020MITHRA PHARMACEUTICALS S A : Signs License and Supply Agreement for Commercialization of M..
AQ
2020MITHRA PHARMACEUTICALS S A : Signs License and Supply Agreement for Commercialization of M..
PU
2020MITHRA PHARMACEUTICALS S A : - Publication of a Transparency Notification Received from Og..
AQ
2020MITHRA PHARMACEUTICALS S A : Signs LSA for Commercialization of Myring in France, Poland a..
AQ
2020Mithra Announces FDA Filing Acceptance of New Drug Application for Estelle in the US
AQ
2020MAYNE PHARMA : Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the ..
AQ
2020MITHRA PHARMACEUTICALS S A : Announces FDA Filing Acceptance of New Drug Application for E..
PU
2020MITHRA PHARMACEUTICALS S A : Notice of Extraordinary Shareholders' Meeting on 22th July 20..
PU
2020MITHRA PHARMACEUTICALS S A : Successfully Raises EUR 65 Million By Means of a Private Plac..
PU
2020MITHRA PHARMACEUTICALS S A : Launches Capital Increase By Means of a Private Placement via..
PU
2020MITHRA PHARMACEUTICALS S A : Signs LSA for Commercialization of Tibelia in Liechtenstein a..
AQ
2020MITHRA PHARMACEUTICALS S A : Issues First Put Option Notice Under Capital Agreement with L..
AQ
2020MITHRA PHARMACEUTICALS S A : Issues First Put Option Notice Under Capital Agreement with L..
PU
2020MAYNE PHARMA : signs license agreement for contraceptive in Australia
AQ
2020MITHRA PHARMACEUTICALS S A : Signs License and Supply Agreement with Mayne Pharma for Comm..
PU
2020MITHRA PHARMACEUTICALS S A : Launches a Research Programme on Estetrol's Effect in Covid-1..
AQ
Vorig1   2  3  4  5Volgende
Volgende evenement op MITHRA PHARMACEUTICALS S.A.